TP53 and cancer: Analysis of the distribution of low-VAF calls (VAF range 0.05–5%) from the first set (96 patients, exploration cohort) showed a specific enrichment of variants with VAFs higher than the background noise in exons 4 to 9, the TP53 region commonly mutated in various types of cancer (Supplementary Fig. S7A).